SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-12-008381
Filing Date
2012-08-16
Accepted
2012-08-16 15:38:38
Documents
13
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 10-K a2210744z10-k.htm 10-K 1464037
2 EX-10.9 a2210744zex-10_9.htm EX-10.9 8098
3 EX-23.1 a2210744zex-23_1.htm EX-23.1 3549
4 EX-31.1 a2210744zex-31_1.htm EX-31.1 8521
5 EX-31.2 a2210744zex-31_2.htm EX-31.2 8565
6 EX-32.0 a2210744zex-32_0.htm EX-32.0 6684
13 G1017706.JPG g1017706.jpg GRAPHIC 60000
  Complete submission text file 0001047469-12-008381.txt   11026851

Data Files

Seq Description Document Type Size
7 EX-101.INS arry-20120630.xml EX-101.INS 1383588
8 EX-101.SCH arry-20120630.xsd EX-101.SCH 85011
9 EX-101.CAL arry-20120630_cal.xml EX-101.CAL 91958
10 EX-101.LAB arry-20120630_lab.xml EX-101.LAB 1350866
11 EX-101.PRE arry-20120630_pre.xml EX-101.PRE 633873
12 EX-101.DEF arry-20120630_def.xml EX-101.DEF 469042
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-16633 | Film No.: 121039902
SIC: 2834 Pharmaceutical Preparations